Study identifies risk factors for ICH in AF patients on NOACs
Among atrial fibrillation (AF) patients treated with nonvitamin K antagonist oral anticoagulants (NOACs) for stroke prevention, several parameters predict intracerebral haemorrhage (ICH), including older age, concurrent use of antiplatelet drugs, and hyperlipidaemia, among others, but not HAS-BLED and CHA2DS2-VASc scores, a study has found.